Cargando…

Lurasidone versus Quetiapine for Cognitive Impairments in Young Patients with Bipolar Depression: A Randomized, Controlled Study

The clinical efficacy of lurasidone and quetiapine, two commonly prescribed atypical antipsychotics for bipolar depression, has been inadequately studied in young patients. In this randomized and controlled study, we aimed to compare the effects of these two drugs on cognitive function, emotional st...

Descripción completa

Detalles Bibliográficos
Autores principales:	Diao, Xiangyuan, Luo, Dan, Wang, Dandan, Lai, Jianbo, Li, Qunxiao, Zhang, Peifen, Huang, Huimin, Wu, Lingling, Lu, Shaojia, Hu, Shaohua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9698487/ https://www.ncbi.nlm.nih.gov/pubmed/36422533 http://dx.doi.org/10.3390/ph15111403

Ejemplares similares

Gut microbial clues to bipolar disorder: State‐of‐the‐art review of current findings and future directions
por: Lai, Jianbo, et al.
Publicado: (2020)

Efficacy of Quetiapine Monotherapy and Combination Therapy for Patients with Bipolar Depression with Mixed Features: A Randomized Controlled Pilot Study
por: Wang, Zheng, et al.
Publicado: (2023)

Lurasidone, olanzapine, and quetiapine extended‐release for bipolar depression: A systematic review and network meta‐analysis of phase 3 trials in Japan
por: Kishi, Taro, et al.
Publicado: (2020)

Quetiapine monotherapy for bipolar depression
por: Thase, Michael E
Publicado: (2008)

Convulsive syncope related to a small dose of quetiapine in an adolescent with bipolar disorder
por: Lai, Jianbo, et al.
Publicado: (2017)

Characteristics of the gut microbiota in bipolar depressive disorder patients with distinct weight
por: Zhang, Peifen, et al.
Publicado: (2023)

Lurasidone for the treatment of bipolar depression: an evidence-based review
por: Franklin, Rachel, et al.
Publicado: (2015)

Management of bipolar I depression: clinical utility of lurasidone
por: Findlay, Lillian Jan, et al.
Publicado: (2015)

Involvement of Kynurenine Metabolism in Bipolar Disorder: An Updated Review
por: Zhang, Peifen, et al.
Publicado: (2021)

Lurasidone in the Treatment of Bipolar Depression: Systematic Review of Systematic Reviews
por: Fornaro, Michele, et al.
Publicado: (2017)

Thyroid functions in patients with bipolar disorder and the impact of quetiapine monotherapy: a retrospective, naturalistic study
por: Li, Chao, et al.
Publicado: (2019)

Impaired blood‐brain barrier in the microbiota‐gut‐brain axis: Potential role of bipolar susceptibility gene TRANK1
por: Lai, Jianbo, et al.
Publicado: (2021)

Lurasidone: a novel antipsychotic agent for the treatment of schizophrenia and bipolar depression
por: Loebel, Antony, et al.
Publicado: (2015)

Lurasidone for Treating Schizophrenia and Bipolar Depression: A Review of Its Efficacy
por: Tarzian, Martin, et al.
Publicado: (2023)

Cost of Relapse Management in Patients with Schizophrenia in Italy and Spain: Comparison Between Lurasidone and Quetiapine XR
por: Restelli, Umberto, et al.
Publicado: (2020)

Lurasidone as a potential therapy for bipolar disorder
por: Woo, Young Sup, et al.
Publicado: (2013)

Sleep Disturbance, Irritability, and Response to Lurasidone Treatment in Children and Adolescents with Bipolar Depression
por: Singh, Manpreet K., et al.
Publicado: (2023)

Effects of quetiapine on sleep architecture in patients with unipolar or bipolar depression
por: Gedge, Laura, et al.
Publicado: (2010)

PS37. Lurasidone in the Treatment of Bipolar Depression: Effect of Baseline Depression Severity on Clinical Outcome
por: Pikalov, Andrei, et al.
Publicado: (2016)

Hospitalization outcomes in patients with schizophrenia after switching to lurasidone or quetiapine: a US claims database analysis
por: Newcomer, John W., et al.
Publicado: (2018)

Double‐blind, placebo‐controlled study of lurasidone monotherapy for the treatment of bipolar I depression
por: Kato, Tadafumi, et al.
Publicado: (2020)

Tolerability, Safety, and Effectiveness of Two Years of Treatment with Lurasidone in Children and Adolescents with Bipolar Depression
por: DelBello, Melissa P., et al.
Publicado: (2021)

TULIP study: Trail of Lurasidone in bipolar disorder in Pakistan()
por: Khan, Nasar, et al.
Publicado: (2021)

New Evidence of Gut Microbiota Involvement in the Neuropathogenesis of Bipolar Depression by TRANK1 Modulation: Joint Clinical and Animal Data
por: Lai, Jianbo, et al.
Publicado: (2021)

Quetiapine for acute bipolar depression: a systematic review and meta-analysis
por: Suttajit, Sirijit, et al.
Publicado: (2014)

PM413. Metabolic Syndrome in Patients With Schizophrenia Receiving Long-Term Treatment With Lurasidone, Quetiapine XR, or Risperidone
por: Newcomer, John W., et al.
Publicado: (2016)

Gut Microbiota Changes in Patients with Bipolar Depression
por: Hu, Shaohua, et al.
Publicado: (2019)

Effects on health-related quality of life in patients treated with lurasidone for bipolar depression: results from two placebo controlled bipolar depression trials
por: Rajagopalan, Krithika, et al.
Publicado: (2016)

Gut Microbiota in Bipolar Depression and Its Relationship to Brain Function: An Advanced Exploration
por: Lu, Qiaoqiao, et al.
Publicado: (2019)

Gut Microbiota – A Potential Contributor in the Pathogenesis of Bipolar Disorder
por: Zhang, Peifen, et al.
Publicado: (2022)

A diagnostic test to examine early improvement as a predictor of later response to lurasidone in bipolar depression
por: Kishi, Taro, et al.
Publicado: (2023)

Change in daytime sleepiness and cognitive function in a 6-month, double-blind study of lurasidone and quetiapine XR in patients with schizophrenia
por: Harvey, Philip D., et al.
Publicado: (2016)

Quetiapine as add-on treatment for bipolar I disorder: efficacy in preventing relapse of depressive episodes
por: Hardoy, Maria Carolina, et al.
Publicado: (2007)

Comparative economic evaluation of quetiapine plus lamotrigine combination vs quetiapine monotherapy (and folic acid vs placebo) in patients with bipolar depression (CEQUEL)
por: Simon, Judit, et al.
Publicado: (2018)

Relationship of Brain Glutamate Response to D-Cycloserine and Lurasidone to Antidepressant Response in Bipolar Depression: A Pilot Study
por: Dong, Zhengchao, et al.
Publicado: (2021)

Role of extended release quetiapine in the management of bipolar disorders
por: Al Jurdi, Rayan K, et al.
Publicado: (2010)

Quetiapine monotherapy versus placebo in the treatment of children and adolescents with bipolar depression: a systematic review and meta-analysis
por: Maneeton, Benchalak, et al.
Publicado: (2017)

Daytime sleepiness associated with lurasidone and quetiapine XR: results from a randomized double-blind, placebo-controlled trial in patients with schizophrenia
por: Loebel, Antony D., et al.
Publicado: (2013)

Quetiapine monotherapy in bipolar II depression: combined data from four large, randomized studies
por: Young, Allan H, et al.
Publicado: (2013)

PS34. Effect of Quetiapine XR on Circadian Rhythm Compared with Lithium in Patients with Bipolar Depression
por: Choi, Jae-Won, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_ra4e4lcl4924rovbh0u6svatav